Skip to main content

MEYER HANDELMAN CO

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 45319 RYE BROOK, NY

Position in REGN

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$1,994,183
-$227,258 QoQ
Shares Held
2,581
-10.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MEYER HANDELMAN CO holds $2,771,741 across 4 Biotechnology names. REGN ranks #1 (71.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
2,581 $1,994,183

All Filings in REGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,994,183 2,581
2025-12-31 $2,221,441 2,878
2025-09-30 $1,608,092 2,860
2025-06-30 $1,822,800 3,472
2025-03-31 $2,533,114 3,994
2024-12-31 $2,934,087 4,119
2024-09-30 $4,478,282 4,260
2024-06-30 $4,482,642 4,265
2024-03-31 $4,105,019 4,265
2023-12-31 $3,745,906 4,265
2023-09-30 $3,485,235 4,235
2023-06-30 $2,730,452 3,800
2023-03-31 $2,937,470 3,575
2022-12-31 $2,528,822 3,505
2022-09-30 $2,517,819 3,655
2022-06-30 $2,131,023 3,605
2022-03-31 $2,517,804 3,605
2021-12-31 $1,986,130 3,145
2021-09-30 $1,797,384 2,970
2021-06-30 $1,658,863 2,970
2021-03-31 $1,062,199 2,245